This study aimed to determine whether immuno‐nutritional and inflammatory markers could serve as predictors of the outcomes of postoperative adjuvant chemotherapy for stage III colorectal cancer in elderly patients. Postoperative lymphocyte‐to‐monocyte ratio and postoperative C‐reactive protein‐to‐albumin ratio accurately predicted the efficacy of ...
Tomoya Tago +6 more
wiley +1 more source
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis. [PDF]
Kim H +9 more
europepmc +1 more source
Peritoneal metastasis histological grade independently predicts outcome in pseudomyxoma peritonei treated with curative surgery. [PDF]
Hasan A +13 more
europepmc +1 more source
Application of artificial intelligence based on contrast-enhanced CT imaging for predicting peritoneal metastasis in patients with T3/T4 stage gastric cancer. [PDF]
Zhang C +6 more
europepmc +1 more source
Case Report: Diagnostic and therapeutic reflections on one case of greater omental adhesion misdiagnosed as peritoneal metastasis following rectal cancer surgery. [PDF]
Li C +6 more
europepmc +1 more source
Peritoneal Metastasis in Advanced Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion/T790M with STRN::ALK Fusion and EGFR Kinase Domain Duplication: Two Case Reports and a Narrative Literature Summary. [PDF]
Zhang H, Han J, Rong F.
europepmc +1 more source
CT semantic features of primary gastric cancer: a preoperative predictive model for peritoneal metastasis with superior efficacy to conventional direct CT assessment. [PDF]
Chen S, Zhang H, Chen Y, Chen S.
europepmc +1 more source
Pathophysiology of Peritoneal Metastasis
ABSTRACTPeritoneal metastasis is the result of a complex, stepwise process that involves multiple, spatially and temporally distinct interactions between the primary cancer, disseminated cancer cells or clusters, and the mesothelial lining of the peritoneal cavity and intraperitoneal organs.
Wim Ceelen +2 more
exaly +4 more sources
Related searches:
Advances with pharmacotherapy for peritoneal metastasis
Expert Opinion on Pharmacotherapy, 2020A new treatment strategy involving cytoreductive surgery (CRS) combined with perioperative intraperitoneal (IP) chemotherapy was proposed in 1999 by the Peritoneal Surface Oncology Group International, and the strategy is now justified as a state-of-the-art treatment to improve the long-term survival of patients with peritoneal metastasis (PM).
Yutaka, Yonemura +10 more
openaire +2 more sources

